630 related articles for article (PubMed ID: 34358389)
1. Decline in Sars-CoV-2 antibodies over 6-month follow-up in obstetrical healthcare workers.
Kiefer MK; Allen KD; Russo JR; Ma'ayeh M; Gee SE; Kniss D; Cackovic M; Costantine MM; Rood KM
Am J Reprod Immunol; 2021 Dec; 86(6):e13490. PubMed ID: 34358389
[TBL] [Abstract][Full Text] [Related]
2. Incidence of SARS-CoV-2 seropositivity in pediatric healthcare workers prior to widespread vaccination: A 5-month longitudinal cohort study.
Griffiths M; Hatabah D; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Heilman S; Camacho-Gonzalez A; Leake D; Korman R; Le M; Suthara M; Wrammert J; Vos MB; Morris CR
Int J Infect Dis; 2024 Jul; 144():107064. PubMed ID: 38641316
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study.
Kohler PP; Kahlert CR; Sumer J; Flury D; Güsewell S; Leal-Neto OB; Notter J; Albrich WC; Babouee Flury B; McGeer A; Kuster S; Risch L; Schlegel M; Vernazza P
Infect Control Hosp Epidemiol; 2021 May; 42(5):604-608. PubMed ID: 33028454
[TBL] [Abstract][Full Text] [Related]
5. Quantitative SARS-CoV-2 Antibody Screening of Healthcare Workers in the Southern Part of Kyoto City During the COVID-19 Pre-pandemic Period.
Fujita K; Kada S; Kanai O; Hata H; Odagaki T; Satoh-Asahara N; Tagami T; Yasoda A
Front Public Health; 2020; 8():595348. PubMed ID: 33365297
[No Abstract] [Full Text] [Related]
6. Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study.
Mortgat L; Verdonck K; Hutse V; Thomas I; Barbezange C; Heyndrickx L; Fischer N; Vuylsteke B; Kabouche I; Ariën KK; Desombere I; Duysburgh E
BMJ Open; 2021 Jun; 11(6):e050824. PubMed ID: 34187832
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis.
Hossain A; Nasrullah SM; Tasnim Z; Hasan MK; Hasan MM
EClinicalMedicine; 2021 Mar; 33():100770. PubMed ID: 33718853
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 active infection and antibodies amongst health personnel during the outbreak in Cameroon: Strengthening the health system for response to future public health emergencies.
Ngomtcho SCH; Akenji BM; Tchio-Nighie KH; Fokam J; Guenou E; Nsa'Amang Eyebe C; Nzegni Kamkoum YJ; Ntale Tchoffo VD; Buh Nkum C; Tchoudjin Paho HC; Ebogo YMS; Nanfak A; Maidadi-Foudi M; Fouda C; Andigema AS; Nsah Bongdze-Em L; Nfor BN; Torimiro J; Zoung-Kanyi Bissek AC; Noubom M; Assoumou Okomo MC; Ateudjieu J
PLoS One; 2024; 19(5):e0304477. PubMed ID: 38820301
[TBL] [Abstract][Full Text] [Related]
9. Geographic heterogeneity of SARS-CoV-2 circulation in Abidjan, Ivory Coast: a prospective study.
Doumbia M; Sevede D; Kouakou V; Pineau P
J Infect Dev Ctries; 2024 May; 18(5):679-686. PubMed ID: 38865396
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study.
Lawal BJ; Gallagher KE; Kitonsa J; Tindanbil D; Kasonia K; Drammeh A; Lowe B; Mukadi-Bamuleka D; Patterson C; Greenwood B; Samai M; Leigh B; Tetteh KKA; Ruzagira E; Watson-Jones D; Kavunga-Membo H
Int J Infect Dis; 2023 Jun; 131():183-192. PubMed ID: 37001799
[TBL] [Abstract][Full Text] [Related]
11. Occupational Exposure in the Lombardy Region (Italy) to SARS-CoV-2 Infection: Results from the MUSTANG-OCCUPATION-COVID-19 Study.
Della Valle P; Fabbri M; Madotto F; Ferrara P; Cozzolino P; Calabretto E; D'Orso MI; Longhi E; Polosa R; Riva MA; Mazzaglia G; Sommese C; Mantovani LG; The Mustang-Occupation-Covid-Study Group
Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33806578
[TBL] [Abstract][Full Text] [Related]
12. Disparities of SARS-CoV-2 Nucleoprotein-Specific IgG in Healthcare Workers in East London, UK.
Choudhry N; Drysdale K; Usai C; Leighton D; Sonagara V; Buchanan R; Nijjar M; Thomas S; Hopkins M; Cutino-Moguel T; Gill US; Foster GR; Kennedy PT
Front Med (Lausanne); 2021; 8():642723. PubMed ID: 33987193
[No Abstract] [Full Text] [Related]
13. Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland.
Stringhini S; Zaballa ME; Pullen N; de Mestral C; Perez-Saez J; Dumont R; Picazio A; Pennacchio F; Dibner Y; Yerly S; Baysson H; Vuilleumier N; Balavoine JF; Bachmann D; Trono D; Pittet D; Chappuis F; Kherad O; Kaiser L; Azman AS; ; Guessous I
Nat Commun; 2021 Jun; 12(1):3455. PubMed ID: 34103517
[TBL] [Abstract][Full Text] [Related]
14. Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Among Healthcare Workers After Vaccine Administration in an Intensive Care Unit.
Lemos C; Ferreira S; Gouveia C; Mendonça É; Mota AM; Rodrigues M; Alves J; Chaves S; Andrade G; Nóbrega JJ
Cureus; 2021 Dec; 13(12):e20579. PubMed ID: 34963873
[TBL] [Abstract][Full Text] [Related]
15. Nigeria healthcare worker SARS-CoV-2 serology study: Results from a prospective, longitudinal cohort.
Ojji DB; Sancilio A; Shedul GL; Orji IA; Chopra A; Abu J; Akor B; Ripiye N; Akinlade F; Okoye D; Okpetu E; Eze H; Odoh E; Baldridge AS; Tripathi P; Abubakar H; Jamda AM; Hirschhorn LR; McDade T; Huffman MD
PLOS Glob Public Health; 2023; 3(1):e0000549. PubMed ID: 36962953
[TBL] [Abstract][Full Text] [Related]
16. Long-term immune responses in patients with confirmed novel coronavirus disease-2019: a 9-month prospective cohort study in Shanghai, China.
Gong X; Cui P; Wu H; Pan H; Teng Z; Yuan F; Mao S; Kong D; Han R; Zhao X; Zheng Y; Xiao W; Zhu Y; Fang Q; Lin S; Jin B; Chu R; Jiang C; Yu X; Qiu Q; Lu Y; Wang W; Fu C; Sun X
BMC Infect Dis; 2022 Mar; 22(1):240. PubMed ID: 35272627
[TBL] [Abstract][Full Text] [Related]
17. Frequency of Anti-SARS-CoV-2 Antibodies in Various Occupational Sectors in an Industrialized Area of Northern Italy from May to October 2020.
Modenese A; Mazzoli T; Berselli N; Ferrari D; Bargellini A; Borella P; Filippini T; Marchesi I; Paduano S; Vinceti M; Gobba F
Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360241
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Viral Incidence, Antibody Point Prevalence, Associated Population Characteristics, and Vaccine Attitudes, South Carolina, February 2021.
Nolan MS; Daguise V; Davis M; Duwve JM; Sherrill WW; Heo M; Litwin AH; Kanyangarara M; Self S; Huang R; Eberth JM; Gual-Gonzalez L; Lynn MK; Korte J;
Public Health Rep; 2022; 137(3):457-462. PubMed ID: 35264040
[TBL] [Abstract][Full Text] [Related]
19. Persistence of SARS-CoV-2 antibodies beyond 6 months in health care workers in Mumbai.
Singhal T; Shah S; Naik R; Kazi A; Thakkar P
Indian J Med Microbiol; 2021 Apr; 39(2):267. PubMed ID: 33647334
[No Abstract] [Full Text] [Related]
20. Prevalence of IgG antibodies to SARS-CoV-2 among emergency department employees.
Madsen T; Levin N; Niehus K; Law K; Mayer J; Chapman M; Johnson A; Hartsell S
Am J Emerg Med; 2020 Dec; 38(12):2752. PubMed ID: 32386808
[No Abstract] [Full Text] [Related]
[Next] [New Search]
